Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1984-01-13
1985-12-31
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544113, 544211, 544212, 544208, 544209, 544213, 544210, 544204, 544194, C07D25146, C07D25152, C07D25116, A61K 3153
Patent
active
045621888
ABSTRACT:
A method for the treatment of irritable bowel syndrome using a 1,3,5-triazin-2-one and a class of 6-amino and 6-mercaptyl-1,3,5-triazin-2-one compounds.
REFERENCES:
patent: 4198409 (1980-04-01), Yelnosky et al.
patent: 4246409 (1981-01-01), Douglas et al.
patent: 4387225 (1983-06-01), Douglas et al.
patent: 4406897 (1983-09-01), Campbell et al.
patent: 4452980 (1984-06-01), Douglas et al.
Campbell Henry F.
Kuhla Donald E.
Studt William L.
Yelnosky John
Barron Alexis
Ford John M.
Nicholson James A.
Savitzky Martin F.
William H. Rorer, Inc.
LandOfFree
Triazinones for treating irritable bowel syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazinones for treating irritable bowel syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazinones for treating irritable bowel syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1024922